Results 41 to 50 of about 24,009 (265)

Prevalence of drug-herb and drug-supplement interactions in older adults : A cross-sectional survey [PDF]

, 2018
© British Journal of General PracticeBackground Polypharmacy is common among older adults, with increasing numbers also using prescription drugs with herbal medicinal products (HMPs) and dietary supplements.
Agbabiaka, Alsanad, Arcury, Batanero-Hernán, Blalock, Claire Goodman, Djuv, Farina, Ginter, Gonzàlez-Stuart, Ly, McLay, Neil H Spencer, Peklar, Porqueddu, Qato, Sabina Khanom, Schnabel, Steyn, Taofikat B Agbabiaka   +19 more
core   +2 more sources

Randomised clinical trial: tegoprazan, a novel potassium‐competitive acid blocker, or lansoprazole in the treatment of gastric ulcer

Alimentary Pharmacology and Therapeutics, 2020
Summary Background Tegoprazan is a novel potassium‐competitive acid blocker for the treatment of acid‐related disorders. Aims To assess whether tegoprazan is non‐inferior to lansoprazole in terms of efficacy and safety in patients with gastric ulcers ...
Y. Cho, Myung-Gyu Choi, S. Choi, K. Lee, Tae Oh Kim, Soo-Heon Park, J. Moon, Y. Lim, D. Kang, G. Cheon, G. Baik, Kyoung-Oh Kim, K. Cho, J. Jang, Jong-Jae Park, B. Son, H. Jung, Byung-Wook Kim, Sung kuk Kim, Soo Teik Lee, J. Cha, A. R. Kim, E. Kim, Hyun Wook Park, G. Song   +24 more
semanticscholar   +1 more source

PERBEDAAN SKOR RSI PENDERITA LARYNGOPHARYNGEAL REFLUX YANG MENDAPAT OMEPRZOLE DAN LANSOPRAZOLE

Jurnal Kedokteran Diponegoro, 2018
Latar Belakang : Laryngopharyngeal Reflux (LPR) adalah hasil aliran balik isi lambung ke laring faring yang menyebabkan cedera mukosa laring dan faring. Reflux Symptom Index (RSI) digunakan sebagai diagnosis dan evaluasi terapi LPR.
Sri Endah Eka Putri, Willy Yusmawan, Kanti Yunika   +2 more
doaj   +1 more source

Functional involvement of PHOSPHO1 in matrix vesicle-mediated skeletal mineralization [PDF]

, 2007
UNLABELLED: PHOSPHO1 is a phosphatase highly expressed in bone. We studied its functional involvement in mineralization through the use of novel small molecule inhibitors.
Ali, Anderson, Anderson, Anderson, Anderson, Anderson, Anderson, Anderson, Baykov, Bernard, Cecil, Colin Farquharson, Dympna Harmey, Fallon, Fawzi, Garimella, Gomez, Harmey, Harmey, Hatch, Hessle, Ho, Houston, Houston, Houston, Hoylaerts, Hsu, Hunter, Johnson, Johnson, José Luis Millán, Kanehisa, Kvam, Lanzafame, Majeska, McLean, Meyer, Miao, Montessuit, Montessuit, Morris, Moss, Murshed, Nagaya, Narisawa, Nurnberg, Pelech, Rezende, Roberts, Roberts, Robison, Schinke, Scott Roberts, Sodek, Sonoko Narisawa, Stewart, Stewart, Suzuki, Terkeltaub, Valhmu, Wang, Wang, Waymire, Whyte, Wu, Wu, Wu, Zelinski   +67 more
core   +1 more source

Development of a Multifunctional Oral Dosage Form via Integration of Solid Dispersion Technology with a Black Seed Oil-Based Self-Nanoemulsifying Drug Delivery System

Biomedicines, 2023
Lansoprazole (LZP) is used to treat acid-related gastrointestinal disorders; however, its low aqueous solubility limits its oral absorption. Black seed oil (BSO) has gastroprotective effects, making it a promising addition to gastric treatment regimens ...
Abdelrahman Y. Sherif, Ahmad Abdul-Wahhab Shahba   +1 more
doaj   +1 more source

Pharmacological Inhibition of PHOSPHO1 Suppresses Vascular Smooth Muscle Cell Calcification [PDF]

, 2013
Medial vascular calcification (MVC) is common in patients with chronic kidney disease, obesity, and aging. MVC is an actively regulated process that resembles skeletal mineralization, resulting from chondro-osteogenic transformation of vascular smooth ...
Chen, Chung, Ciancaglini, Dahl, Delomenede, Doherty, El-Abbadi, Fleisch, Gremse, Grosdidier, Grosdidier, Harmey, Hessle, Houston, Houston, Hsu, Huesa, Jaroszewski, Johnson, Jono, Kapustin, Kozlenkov, Lomashvili, Lyemere, MacRae, Markello, Nakano-Kurimoto, Narisawa, O'Neill, Qiao, Roberts, Roberts, Roy, Schwede, Sergienko, Sergienko, Shanahan, Shroff, Sidique, Stewart, Stewart, Towler, Towler, Tyson, van der Zee, Villa-Bellosta, Yadav, Zhu   +47 more
core   +1 more source

Pharmacologic Properties of Proton Pump Inhibitors [PDF]

, 2003
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/90231/1/phco.23.13.74S.31929 ...
Welage, Lynda S.
core   +1 more source

The Pharmacogenetics of Cytochrome P450 2C19 Enzymes - Effects on Clopidogrel and Proton Pump Inhibitors [PDF]

, 2014
BACKGROUND: Cytochrome P450 (CYP) enzymes play important roles in human, including drug metabolism. CYP2 is the largest family of human CYP, with its sequence comprising almost one third of all CYP sequences, and responsible for the metabolism of ...
Muliaty, D. (Dewi), Yusmiati, Y. (Yusmiati)   +1 more
core   +4 more sources

Pharmacodynamics and Pharmacokinetics of a New Type of Compound Lansoprazole Capsule in Gastric Ulcer Rats and Beagle Dogs: Importance of Adjusting Oxidative Stress and Inflammation

Pharmaceutics, 2019
: The aim of this study was to investigate the pharmacodynamics and pharmacokinetics of a new type of compound lansoprazole capsule in gastric ulcer rats and beagle dogs in order to confirm whether it is more effective in treating gastric ulcers and its ...
Binbin Wei, Yan Wang, Huizhe Wu, Mingyan Liu, Weifan Yao, Minjie Wei   +5 more
doaj   +1 more source

Head-to-head comparison of H2-receptor antagonists and proton pump inhibitors in the treatment of erosive esophagitis: A meta-analysis [PDF]

, 2005
Aim: To systematically evaluate the efficacy of H2-receptor antagonists (H2RAs) and proton pump inhibitors in healing erosive esophagitis (EE). Methods: A meta-analysis was performed.
Huang, JQ, Lam, SK, Wang, WH, Wong, BCY, Wong, WM, Xia, HHX, Zheng, GF   +6 more
core   +1 more source